Q4 2020 Auris Medical Holding Ltd Earnings Call Transcript
Good day, and thank you for standing by. And welcome to the Auris Medical to Provide Business Updates on AM-301 Program Call. (Operator Instructions) I must advise you that this call is being recorded today, Tuesday, the 13th of April 2021. (Operator Instructions)
And earlier today, Auris Medical issued a news release announcing preclinical and clinical outcomes with AM-301 and detailing plans for market launch. The release is available on the company's website aurismedical.com and filed with the SEC.
During today's call, Auris Medical will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating, financial or business performance or the company's strategies or expectations. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that cause -- that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks are -- these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |